基于网络药理学和分子对接探究藜麦籽粒中三萜皂苷类化合物抗糖尿病作用机制  

Exploring the Anti-diabetic Mechanism of Triterpene Saponins in Quinoa Grain Based on Network Pharmacology and Molecular Docking

作　　者：谭霓霞 董琦[2] Tan Nixia;Dong Qi(Department of Pharmacy,Medical College of Qinghai University,Xining 810001,China;Northwest Institute of Plateau Biology,Chinese Academy of Sciences,Xining 810008,China)

机构地区：[1]青海大学医学院药学系,西宁810001 [2]中国科学院西北高原生物研究所,西宁810008

出　　处：《青海科技》2024年第6期47-62,共16页Qinghai Science and Technology

基　　金：青海省应用基础研究计划项目“藜麦皂苷降血糖作用机制及物质基础研究”(2023-ZJ-760);湖州市重点研发计划项目“藜麦种质资源库的构建及应用研究”(2023ZD2035)。

摘　　要：籽粒作为藜麦可食用部分,被证明富含黄酮、多酚、皂苷等生物活性成分。藜麦籽粒皂苷类化合物在治疗2型糖尿病方面具有潜在的作用,但其治疗作用机制尚不清楚且相关研究较少。文章通过网络药理学对藜麦籽粒中的三萜皂苷治疗2型糖尿病的作用机制进行探讨,结果发现这些三萜皂苷类化合物可能通过HIF-1、PI3K/AKT等信号通路发挥治疗作用;并通过分子对接对预测到的靶点进行验证,结果显示化合物22与MTOR、STAT3、MAPK1以及TLR4等靶点的对接亲和力较高。The grain,as the edible part of quinoa,has been shown to be rich in bioactive components such as flavonoids,polyphenols,and saponins.Quinoa grain saponins have a potential role in treating type 2 diabetes mellitus(T2DM),but the underlying mechanism is still unclear and related studies are few.In this paper,the mechanism of triterpene saponins in quinoa grain in the treatment of T2DM was explored through network pharmacology.The results showed that these triterpene saponins may play a therapeutic role through HIF-1,PI3K/AKT signaling pathways.The predicted targets were verified by molecular docking.The results showed that compound 22 had high docking affinities with MTOR,STAT3,MAPK1 and TLR4.

关 键 词：藜麦籽粒 三萜皂苷 2型糖尿病 网络药理学 分子对接 

分 类 号：R961[医药卫生—药理学]